InMed Pharmaceuticals Inc.
INM
$2.96
$0.24378.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -74.20% | 33.86% | -472.61% | 13.76% | 29.65% |
| Total Depreciation and Amortization | -15.40% | -2.95% | 0.60% | 1.01% | 3.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.75% | -71.82% | 143.96% | 12.50% | 97.47% |
| Change in Net Operating Assets | 86.74% | -449.63% | 352.60% | -395.35% | 16.90% |
| Cash from Operations | -35.39% | 15.98% | -56.44% | -16.76% | 31.88% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | 100.00% | 100.00% | 98.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -92.40% | -- | -- | -- | 9.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 89.75% | -- | -- | -- | -198.41% |
| Cash from Financing | -92.73% | -- | -- | 100.00% | -12.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.37% | 54.53% | -48.81% | -4.64% | 33.03% |